NP47818 Glatiramer Injection

Tender description

The Framework Agreement is for the supply of Glatiramer Acetate Injection in 20mg and 40mg presentations to NHS Scotland. Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioning Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority. Lot 1: Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service. This Lot is for the supply of 20mg and 40mg Glatiramer Acetate Injection direct to hospitals or direct to patients in their own home, or other designated address, via a manufacturer commissioned Home Delivery Service. Lot 2: Glatiramer Acetate Injection excluding a manufacturer commissioning Home Delivery Service This Lot is for the supply of 20mg and 40mg glatiramer acetate injection direct to hospitals or nominated Home Delivery supplier(s) as directed by Participating Authorities and/or the Authority.